Another approach to study the role of Nrf2 in HFD-induced obesity and T2D is the use of pharmacological substances that activate the Keap1/Nrf2 pathway by interacting with the reactive cysteines in Keap1 and accelerate nuclear accumulation of Nrf2. The gene discussed is KEAP1; the disease is obesity due to melanocortin 4 receptor deficiency.